A federal court ruled that Brianne Dressen’s lawsuit against AstraZeneca can proceed, rejecting the company’s claim of immunity under the PREP Act. Dressen, who was injured during a COVID-19 vaccine trial, sued for breach of contract after AstraZeneca allegedly failed to provide promised medical care. The court found that the PREP Act does not protect against breach-of-contract claims but covers product liability issues, which Dressen’s case does not involve. AstraZeneca’s minimal compensation offer was criticized, and the ruling could open the door to similar lawsuits. Dressen, now disabled, seeks compensation for extensive medical costs.
Editor’s Note: This is an important step toward holding pharmaceutical corporations accountable for their activities during the COVID-19 outbreak. These firms have functioned under the protection of immunity, allowing them to implement emergency countermeasures without fear of repercussions. This allowed them to ignore their commitments to clinical trial participants and the general public.
Pharmaceutical giants made record profits during the pandemic at the expense of public trust, transparency, and safety. The paltry compensation granted to Dressen for her life-altering disabilities demonstrates these firms’ arrogance and carelessness when it comes to dealing with the consequences of hasty vaccination rollouts. [See also: AstraZeneca Admits in Court: COVID Shots Can Cause Dangerous Side Effects, AstraZeneca Withdraws COVID Vaccine Worldwide]
Read Original Article
Read Online
Click the button below if you wish to read the article on the website where it was originally published.
Read Offline
Click the button below if you wish to read the article offline.